Myriad Genetics (MYGN) Q2 2026 Earnings

5MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.09
-0.04
0
0.05

Details

Expected EPS
-0.068027
Actual EPS
-0.09
Surprise EPS
-0.02
Surprise Percent
+32.3%

Description

Myriad Genetics (MYGN) has reported earnings of -0.09 per share for Q2 2026.

0 Comments

Share your thoughts